Almonte M., Murillo R., Sanchez G.I., Gonzalez P., Ferrera A., Picconi M.A., Wiesner C., Cruz-Valdez A., Lazcano-Ponce E., Jeronimo J., Ferreccio C., Kasamatsu E., Mendoza L., Rodriguez G., Calderon A., Venegas G., Villagra V., Tatti S., Fleider L., Teran C., Baena A., Hernandez M.L., Rol M.L., Lucas E., Barbier S., Ramirez A.T., Arrossi S., Rodriguez M.I., Gonzalez E., Celis M., Martinez S., Salgado Y., Ortega M., Beracochea A.V., Perez N., Rodriguez de la Pena M., Ramon M., Hernandez-Nevarez P., Arboleda-Naranjo M., Cabrera Y., Salgado B., Garcia L., Retana M.A., Colucci M.C., Arias-Stella J., Bellido-Fuentes Y., Bobadilla M.L., Olmedo G., Brito-Garcia I., Mendez-Herrera A., Cardina L., Flores B., Penaranda J., Martinez-Better J., Soilan A., Figueroa J., Caserta B., Sosa C., Moreno A., Mural J., Doimi F., Gimenez D., Rodriguez H., Lora O., Luciani S., Broutet N., Darragh T., Herrero R. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open 2020;10:e035796. |
Arbyn M., Bruni L., Kelly D., Basu P., Poljak M., Gultekin M., Bergeron C., Ritchie D., Weiderpass E. Tackling cervical cancer in Europe amidst the COVID-19 pandemic. Lancet Public Health. 2020 Jul 13;S2468-2667(20)30122-5. |
Arbyn M., Gultekin M., Morice P., Nieminen P., Cruickshank M., Poortmans P., Kelly D., Poljak M., Bergeron C., Ritchie D., Schmidt D., Kyrgiou M., Van den Bruel A., Bruni L., Basu P., Bray F., Weiderpass E. The European Response to the WHO Call to Eliminate Cervical Cancer as a Public Health Problem. Int J Cancer. 2020 Jul 7. |
Armaroli P., Riggi E., Basu P., Anttila A., Ponti A., Carvalho A.L., Dillner J., Elfstrom M.K., Giordano L., Lonnberg S., Ronco G., Senore C., Soerjomataram I., Tomatis M., Vale D.B., Jarm K., Sankaranarayanan R., Segnan N. Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates. Int J Cancer. 2020 Mar 11. |
Baena A., De Vuyst H., Mesher D., Kasubi M., Yuma S., Mwaiselage J., Zouiouich S., Mlay P., Kahesa C., Landoulsi S., Hernandez M.L., Lucas E., Herrero R., Almonte M., Broutet N. Reproducibility of a rapid human papillomavirus test at different levels of the healthcare system in Tanzania: the AISHA study. Cancer Epidemiol Biomarkers Prev. August 20 2020. |
Banerjee D., Mandal R., Mandal A., Ghosh I., Mittal S., Muwonge R., Lucas E., Basu P. A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting. Asian Pac J Cancer Prev. 2020 May 1;21(5):1391-1398. |
Basu P. Healthcare Systems Need to be Organized to Fight two Pandemics Simultaneously. Asian Pacific Journal of Cancer Care, 5(S1), 1-3. |
Bhatla N., Meena J., Gupta K., Pal B., Divakar H., Bhalerao S., Peedicayil A., Srivastava S., Basu P., Purandare C.N.; FOGSI Expert Group. Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India. J Obstet Gynaecol Res. 2020 Jul 6. |
Bhatla N., Nessa A., Oswal K., Vashist S., Sebastian P., Basu P. Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India. Int J Gynaecol Obstet. 2020 Nov 18. |
Castle P.E., Pierz A.J., Adcock R., Aslam S., Basu P.S., Belinson J.L., Cuzick J., El-Zein M., Ferreccio C., Firnhaber C., Franco E.L., Gravitt P.E., Isidean S.D., Lin J., Mahmud S.M., Monsonego J., Muwonge R., Ratnam S., Mahboobeh Safaeian M., Schiffman M., Smith J.S., Swarts A., Wright T., Van De Wyngard V., Xi L.F. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prev Res (Phila). 2020 Jul 12:canprevres.0182.2020. |
Escriva-Boulley G., Mandrik O., Preau M., Herrero R., Villain P. Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review. Prev Med. 2020 Nov 7:106323. |
Joshi S., Mane A., Muwonge R., Divate U., Padbidri V., Kulkarni V., Gangakhedkar R., Sankaranarayanan R. Prevalence and predictors of bacterial vaginosis in HIV-infected women in Maharashtra, India. Int J STD AIDS. 2020 Mar 31:956462419878333. |
Kumar S., Khanduri A., Sidibe A., Morgan C., Torode J., Basu P., Bhatla N., Schocken C., Bloem P. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries. Int J Gynaecol Obstet. 2020 Nov 13. |
Mandal R., Ghosh I., Banerjee D., Mittal S., Muwonge R., Roy C., Panda C., Vernekar M., Frappart L., Basu P. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias. Int J Gynecol Pathol. 2020 Jul;39(4):384-390. |
Mariz F.C., Bender N., Anantharaman D., Basu P., Bhatla N., Pillai M.R., Prabhu P.R., Sankaranarayanan R., Eriksson T., Pawlita M., Prager K., Sehr P., Waterboer T., Muller M., Lehtinen M. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. NPJ Vaccines. 2020 Feb 14;5:14. |
Muwonge R., Basu P., Gheit T., Anantharaman D., Verma Y., Bhatla N., Joshi S., Esmy P.O., Poli U.R.R., Shah A., Zomawia E., Shastri S.S., Pimple S., Prabhu P.R., Hingmire S., Chiwate A., Sauvaget C., Lucas E., Malvi S.G., Siddiqi M., Sankaran S., Kannan T.P.R.A., Varghese R., Divate U., Vashist S., Mishra G., Jadhav R., Tommasino M., Pillai M.R., Sankaranarayanan R., Jayant K.; Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. Indian HPV vaccine study group. PLoS One. 2020 Dec 29;15(12):e0244242. |
Poli U.R., Muwonge R., Bhoopal T., Lucas E., Basu P. Feasibility, Acceptability, and Efficacy of a Community Health Worker-Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India. JCO Glob Oncol. 2020 Apr;6:658-666. |
Ponti A., Basu P., Ritchie D., Anttila A., Carvalho A.L., Senore C., Mallafre-Larrosa M., Piccinelli C., Ronco G., Soerjomataram I., Primic-Žakelj M., Dillner J., Elfstrom M.K., Lonnberg S., Vale D.B., Tomatis M., Armaroli P., Giordano L., Sankaranarayanan R., Segnan N. Key issues that need to be considered while revising the current Annex of the European Council Recommendation (2003) on cancer screening. Int J Cancer. 2020 Jan 22. |
Shiko Y., Konno R., Konishi H., Sauvaget C., Ohashi Y., Kakizoe T. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women. BMC Infect Dis. 2020 Nov 5;20(1):808. |
Taghavi K., Moono M., Mwanahamuntu M., Basu P., Limacher A., Tembo T., Kapesa H., Hamusonde K., Asangbeh S., Sznitman R., Low N., Manasyan A., Bohlius J. Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol. BMJ Open 2020;10:e037955. |
Taghavi K., Rohner E., Basu P., Low N., Rutjes A., Bohlius J. Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis. BMC Womens Health. 2020 Nov 16;20(1):253. |
Tsang S.H., Basu P., Bender N., Herrero R., Kemp T.J., Kreimer A.R., Muller M., Panicker G., Pawlita M., Pinto L.A., Sampson J.N., Sankaranarayanan R., Schussler J., Sehr P., Sierra M.S., Unger E.R., Waterboer T., Hildesheim A.; Costa Rica Vaccine Trial (CVT) Group. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. 2020 Jul 23:S0264-410X(20)30917-8. |
Whitworth H.S., Gallagher K.E., Howard N., Mounier-Jack S., Mbwanji G., Kreimer A.R., Basu P., Kelly H., Drolet M., Brisson M., Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 2019 Dec 20. pii: S0264-410X(19)31659-7. |
Zhao X.L., Liu Z.H., Zhao S., Hu S.Y., Muwonge R., Duan X.Z., Du L.J., Su C.F., Xiang X.E., Zhang X., Pan Q.J., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Efficacy of Point-of-care Thermal Ablation Among High-risk Human Papillomavirus Positive Women in China. Int J Cancer. 2020 Sep 7. |
Zhao X.L., Xu X.Q., Duan X.Z., Rezhake R., Hu S.Y., Wang Y., Xia C.F., Zhang X., Qiao Y.L., Sankaranarayanan R., Zhao F.H., Basu P. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: a population-based study in rural China. Int J Cancer. 2020 Jan 22. |
Zhao Y., Zhao F., Hu S., Zhang X., Zhang W., Pan Q., Gage J.C., Sankaranarayanan R., Qiao Y. Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies. Chin J Cancer Res. 2020 Jun;32(3):383-394. |